{"id":"https://openalex.org/W2019096773","doi":"https://doi.org/10.1254/jjp.70.313","title":"Effects of the Endothelin ETA-Receptor Antagonist FR139317 on Development of Hypertension and Cardiovascular Hypertrophy in Deoxycorticosterone Acetate-Salt Hypertensive Rats","display_name":"Effects of the Endothelin ETA-Receptor Antagonist FR139317 on Development of Hypertension and Cardiovascular Hypertrophy in Deoxycorticosterone Acetate-Salt Hypertensive Rats","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2019096773","doi":"https://doi.org/10.1254/jjp.70.313","mag":"2019096773","pmid":"https://pubmed.ncbi.nlm.nih.gov/8774759"},"language":"en","primary_location":{"id":"doi:10.1254/jjp.70.313","doi":"https://doi.org/10.1254/jjp.70.313","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.70.313","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1254/jjp.70.313","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111698651","display_name":"Katsuya Fujita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuya Fujita","raw_affiliation_strings":["Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Japan","Department of Pharmacology, Osaka University of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I90237989"]},{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102419027","display_name":"Yasuo Matsumura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuo Matsumura","raw_affiliation_strings":["Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 2-10-65 Kawai, Matsubara, Osaka 580, Japan","Department of Pharmacology, Osaka University of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 2-10-65 Kawai, Matsubara, Osaka 580, Japan","institution_ids":["https://openalex.org/I90237989"]},{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075085875","display_name":"Yohko Miyazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yohko Miyazaki","raw_affiliation_strings":["Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 2-10-65 Kawai, Matsubara, Osaka 580, Japan","Department of Pharmacology, Osaka University of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 2-10-65 Kawai, Matsubara, Osaka 580, Japan","institution_ids":["https://openalex.org/I90237989"]},{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016752876","display_name":"Masanori Takaoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masanori Takaoka","raw_affiliation_strings":["Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 2-10-65 Kawai, Matsubara, Osaka 580, Japan","Department of Pharmacology, Osaka University of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 2-10-65 Kawai, Matsubara, Osaka 580, Japan","institution_ids":["https://openalex.org/I90237989"]},{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110162962","display_name":"Shiro Morimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shiro Morimoto","raw_affiliation_strings":["Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 2-10-65 Kawai, Matsubara, Osaka 580, Japan","Department of Pharmacology, Osaka University of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 2-10-65 Kawai, Matsubara, Osaka 580, Japan","institution_ids":["https://openalex.org/I90237989"]},{"raw_affiliation_string":"Department of Pharmacology, Osaka University of Pharmaceutical Sciences","institution_ids":["https://openalex.org/I90237989"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I90237989"],"apc_list":null,"apc_paid":null,"fwci":1.5603,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.80723964,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"70","issue":"4","first_page":"313","last_page":"320"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.031199999153614044,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.01810000091791153,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endothelin-1","display_name":"endothelin-1","score":0.9850000143051147},{"id":"https://openalex.org/keywords/eta-receptor-antagonist","display_name":"ETA receptor antagonist","score":0.859000027179718},{"id":"https://openalex.org/keywords/fr139317","display_name":"FR139317","score":0.9990000128746033},{"id":"https://openalex.org/keywords/doca-salt-hypertension","display_name":"DOCA-salt hypertension","score":0.9110000133514404},{"id":"https://openalex.org/keywords/vascular-hypertrophy","display_name":"vascular hypertrophy","score":0.6520000100135803},{"id":"https://openalex.org/keywords/cardiac-hypertrophy","display_name":"cardiac hypertrophy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7260000109672546},{"id":"https://openalex.org/keywords/unilateral-nephrectomy","display_name":"unilateral nephrectomy","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8240113854408264},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7898370027542114},{"id":"https://openalex.org/C167414201","wikidata":"https://www.wikidata.org/wiki/Q1955391","display_name":"Muscle hypertrophy","level":2,"score":0.7452430725097656},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6707313060760498},{"id":"https://openalex.org/C144980905","wikidata":"https://www.wikidata.org/wiki/Q24721308","display_name":"Endothelin receptor","level":3,"score":0.6448062658309937},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5423305034637451},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5076063871383667},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.48094457387924194},{"id":"https://openalex.org/C149601957","wikidata":"https://www.wikidata.org/wiki/Q390566","display_name":"Endothelin 1","level":3,"score":0.44990241527557373},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44679194688796997},{"id":"https://openalex.org/C2776002628","wikidata":"https://www.wikidata.org/wiki/Q1628627","display_name":"Left ventricular hypertrophy","level":3,"score":0.4116295576095581},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34881627559661865}],"mesh":[{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003900","descriptor_name":"Desoxycorticosterone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003900","descriptor_name":"Desoxycorticosterone","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006332","descriptor_name":"Cardiomegaly","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006332","descriptor_name":"Cardiomegaly","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006332","descriptor_name":"Cardiomegaly","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008638","descriptor_name":"Mesenteric Arteries","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008638","descriptor_name":"Mesenteric Arteries","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008638","descriptor_name":"Mesenteric Arteries","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016232","descriptor_name":"Endothelins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016232","descriptor_name":"Endothelins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065128","descriptor_name":"Endothelin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1254/jjp.70.313","doi":"https://doi.org/10.1254/jjp.70.313","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.70.313","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:8774759","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8774759","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1254/jjp.70.313","doi":"https://doi.org/10.1254/jjp.70.313","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.70.313","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W193624571","https://openalex.org/W1566101437","https://openalex.org/W1599556324","https://openalex.org/W1765750524","https://openalex.org/W1965088568","https://openalex.org/W1974365124","https://openalex.org/W1988778211","https://openalex.org/W1989355270","https://openalex.org/W1996049126","https://openalex.org/W1996339595","https://openalex.org/W1998607094","https://openalex.org/W2001624788","https://openalex.org/W2004565142","https://openalex.org/W2037687716","https://openalex.org/W2044261018","https://openalex.org/W2050029151","https://openalex.org/W2053167082","https://openalex.org/W2054381541","https://openalex.org/W2056966654","https://openalex.org/W2068977925","https://openalex.org/W2075888651","https://openalex.org/W2077953197","https://openalex.org/W2078288680","https://openalex.org/W2085751107","https://openalex.org/W2085838621","https://openalex.org/W2089500756","https://openalex.org/W2092591926","https://openalex.org/W2101652320","https://openalex.org/W2109591901","https://openalex.org/W2155982732","https://openalex.org/W2162804111","https://openalex.org/W2258152416","https://openalex.org/W2264432107","https://openalex.org/W2414828581","https://openalex.org/W2416032490","https://openalex.org/W3099042009","https://openalex.org/W6633925301","https://openalex.org/W6692062996","https://openalex.org/W6716116157"],"related_works":["https://openalex.org/W4232430359","https://openalex.org/W2050029151","https://openalex.org/W2004565142","https://openalex.org/W2162820159","https://openalex.org/W2059972325","https://openalex.org/W2001180158","https://openalex.org/W4254975890","https://openalex.org/W2024946823","https://openalex.org/W2208896997","https://openalex.org/W2017462335"],"abstract_inverted_index":{"We":[0],"investigated":[1],"the":[2,8,24,29,75,103,106,117,133,161,169,185,188],"role":[3,159],"of":[4,10,26,163],"endothelin-1":[5],"(ET-1)":[6],"in":[7,15,77,102,116,126,132,140,160,184,192],"development":[9,162],"hypertension":[11,68,165],"and":[12,36,120],"cardiovascular":[13,182,189],"hypertrophy":[14,129,139,183,190],"deoxycorticosterone":[16],"acetate":[17],"(DOCA)-salt":[18],"hypertensive":[19,142,194],"rats.":[20,136],"Two":[21],"weeks":[22],"after":[23,69],"start":[25],"DOCA-salt":[27,58,64,92,135,141,164,193],"treatment,":[28],"rats":[30,56,65,93,104,143,195],"were":[31,37],"divided":[32],"into":[33],"two":[34],"groups":[35],"given":[38,105],"FR139317":[39,72],"[(R)2-[(R)-2-[(S)-2-[[1-(hexahydro-1H-azepinyl)]-":[40],"carbonyl]amino-4-methyl-pentanoyl]amino-3-[3-(1-methyl-1H-indolyl)]":[41],"propionyl]amino-3-(2-pyridyl)":[42],"propionic":[43],"acid],":[44],"a":[45,113],"specific":[46],"ETA-receptor":[47,178],"antagonist,":[48],"or":[49],"its":[50],"vehicle":[51,107],"for":[52],"2":[53],"weeks.":[54,71],"Uninephrectomized":[55],"without":[57],"treatment":[59],"served":[60],"as":[61],"controls.":[62],"Vehicle-treated":[63],"developed":[66],"marked":[67,124],"4":[70],"significantly":[73,146],"suppressed":[74],"increase":[76,115],"systolic":[78],"blood":[79],"pressure":[80],"with":[81,112],"values":[82],"averaging":[83],"163":[84],"+/-":[85,97],"8":[86],"mmHg":[87],"(P":[88],"<":[89],"0.05":[90],"vs":[91],"receiving":[94],"vehicle,":[95],"195":[96],"9":[98],"mmHg).":[99],"Morphological":[100],"studies":[101],"showed":[108],"vascular":[109,127],"medial":[110],"hypertrophy,":[111],"significant":[114],"wall":[118,128],"area":[119],"wall-to-lumen":[121],"ratio.":[122],"A":[123],"decrease":[125],"was":[130,144],"observed":[131],"FR139317-treated":[134],"The":[137],"cardiac":[138],"also":[145],"reduced":[147,181],"by":[148,167],"FR139317.":[149],"Therefore,":[150],"these":[151],"results":[152],"suggest":[153],"that":[154,176],"ET-1":[155],"plays":[156],"an":[157,177],"important":[158],"presumably":[166],"stimulating":[168],"ETA":[170],"receptor.":[171],"In":[172],"addition,":[173],"we":[174],"found":[175],"antagonist":[179],"effectively":[180],"rats,":[186],"so":[187],"noted":[191],"may":[196],"be":[197],"related":[198],"to":[199],"ET-1.":[200]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}